Omalizumab safe, effective for severe chronic rhinosinusitis with nasal polyps
Omalizumab shows good clinical and endoscopic efficacy in patients with severe chronic rhinosinusitis with nasal polyps (CRSwNP), reports two phase III trials, POLYP1 and POLYP2.
Omalizumab safe, effective for severe chronic rhinosinusitis with nasal polyps
20 Sep 2020